Progression-free and overall survival outcomes in patients with cancer treated with immunotherapy could be related to thymic ...

High insurance and overhead costs have closed many rural labor and delivery units, creating maternity deserts.

Multiple viral infections are common after stem cell transplants, especially in patients with CMV exposure, haploidentical donors, or acute graft-vs-host disease or those receiving T-cell depletion.

Overall survival outcomes in MATTERHORN trial support perioperative durvalumab plus chemotherapy as standard of care.

Adding the CDK4/6 inhibitor abemaciclib to endocrine therapy significantly improves overall survival in node-positive, ...

Midwives and family physicians are essential to support mothers facing hypogalactia and maintain WHO-recommended exclusive ...

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of ...

Additional early research suggested that combining metformin and clemastine may promote remyelination, offering hope for ...

The EMA has recommended a first-in-class Bruton’s tyrosine kinase inhibitor to treat immune thrombocytopenia in adults who ...

The EMA says a study did not show clinical benefit, while Sanofi says it will continue to work closely with the regulator to bring the treatment to patients.

The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.